CLINICAL_TRIALS
trial_result
· 2007-01-04
Clinical Trial Update: Study of Nitazoxanide in the Treatment of Clostridium Difficile Colitis [Phase 2]
Summary
Phase 2 clinical trial evaluating nitazoxanide for treating Clostridioides difficile infection has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Romark Laboratories L.C. | Conditions: Clostridium Difficile | Phase 2 | Status: COMPLETED